Proliferation and differentiation of myelodysplastic CD34+ cells

Leukemia and Lymphoma

Volumn 22, Issue 1-2, 1996, Pages 43-51

  Sawada, Ken Ichi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

CD34; Differentiation; MDS; Phenotypic subpopulations; Proliferation

Indexed keywords

CD34 ANTIGEN; COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SUBPOPULATION; COLONY FORMING UNIT; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REVIEW;

EID: 0029950063     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609051727     Document Type: Review

References (127)

1. Saarni, M. I. and Linman, J. W. (1973) Preleukemia: The hematologic syndrome preceding acute leukemia. Am. J. Med., 55, 38-48.
2. Greenberg, P. L. and Mara, B. (1979) The preleukemic syndrome. Correlation of in vitro parameters of granulopoiesis with clinical features. Am. J. Med., 66, 951-958.
3. Koeffler, H. P. and Golde, D. W. (1980) Human preleukemia. Ann. Intern. Med., 93, 347-353.
4. Linman, J. W. and Bagby, G. C. (1983) The smoldering myeloid leukemic states. Clinical and biologic features. Blood, 61, 1035-1044.
5. Greenberg, P. L. (1983) The smoldering myeloid leukemic states. Clinical and biologic features. Blood, 61, 1035-1044.
6. Prchal, J. T., Throckmorton, D. W., Carroll, A. J., Fuson, E. W., Gams, R. A. and Prchal, J. S. (1978) A common progenitor for human myeloid and lymphoid cells. Nature, 274, 590-591.
7. Abkowitz, J. L., Fialkow, P. J., Niebruge, D. J., Raskind, W. H. and Adamson, J. W. (1984) Pancytopenia as a clonal disorder of a multipotent hemopoietic stem cell. J. Clin. Invest., 73, 258-261.
8. Raskind, W. H., Timmali, N., Jacobsen, R., Singer, J. and Fialkow, P. J. (1984) Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood, 63, 1318-1323.
9. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H. R. and Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol., 51, 189-199.
10. Negrin, R. S., Haeuber, D. H., Nagler, A., Olds, L. C., Donlon, T., Souza, L. M. and Greenberg, P. L. (1989) Treatment of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor. A phase I-II trial. Ann. Intern. Med., 110, 976-984.
11. Kobayashi, Y., Okabe, T., Ozawa, K., Chiba, S., Hino, M., Miyazono, K., Urabe, A. and Takaku F. (1989) Treatment of myelodysplastic syndromes with recombinant human granulocytecolony stimulating factor: A preliminary report. Am. J. Med., 86, 178-182.
12. Greenberg, P., Negrin, R., Nagler, A., Vincent, M. and Donlon, T. (1990) Effects of prolonged treatment of myelodysplastic syndromes with recombinant human granulocyte colony- stimulating factor. Int. J. Cell Clon. (Suppl 1), 293-302.
13. Yoshida, Y., Hirashima, K., Asano, S. and Takaku, F. (1991) A phase II trial of recombinant human granulocyte colony-stimulating factor in the myelodysplastic syndromes. Br. J. Hoematol., 78, 378-384.
14. Vadhan-Raj, S., Keating, M., LeMaistre, A., Hittelman, W. N., McCredie, K., Trujillo, J. M., Broxmeyer, H. E., Henney, C. and Gutterman, J. U. (1987) Effects of recombinant human granulocyte-macrophage colony stimulating factor in patients with myelodysplastic syndromes. N. Engl. J. Med., 317, 1545-1552.
15. Antin, J. H., Smith, B. R., Holmes, W. and Rosenthal, D. S. (1988) Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome. Blood, 72, 705-713.
16. Ganser, A., Volkers, B., Greher, J., Ottmann, O. G., Walther, F., Becher, R., Bergmann, L., Schultz, G. and Hoelzer, D. (1989) Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes - A phase I/II trial. Blood, 73, 31-37.
17. Thompson, J. A., Lee, D. J., Kidd, P., Rubin, E., Kaufmann, J., Bonnem, E. M. and Fefer, A. (1989) Subcutaneous granulocytemacrophage colony-stimulating factor in patients with myelodysplastic syndrome: Toxicity, pharmacokinetics, and hematologic effects. J. Clin. Oncol., 7, 629-637.
18. Ganser, A., Seipelt, G., Lindemann, A., Ottman, O. G., Falk, S., Eder, M., Herrmann, F., Becher, R., Hoffken, K., Buchner, T., Klausmann, M., Frish, J., Schulz, G., Mertelsmann, R. and Hoelzer, D. (1990) Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes. Blood, 76, 455-462.
19. Nand, S., Sosman, J., Godwin, J. E. and Fisher, R. (1994) A phase I/II study of sequential interleukin-3 and granulocyte-macrophage colony-stimulating factor in myelodysplastic syndromes. Blood, 83, 357-360.
20. Negrin, R. S., Haeuber, D. H., Nagler, A., Kobayashi, Y., Sklar, J., Donlon, T., Vincent, M. and Greenberg, P. L. (1990) Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony stimulating factor. Blood. 76, 36-43.
21. Kurzrock, R., Talpaz, M., Estrov, Z., Rosenblum, M. G. and Gutterman, J. U. (1991) Phase I study of recombinant human interleukin-3 in patients with bone marrow failure. J. Clin. Oncol., 9, 1241-1250.
22. Anastasi, J., Feng, J., Le Beau, M. M., Larson, R. A., Rowley, J. D. and Vardiman, J. W. (1993) Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion. Blood, 81, 1580-1585.
23. Ganser, A., Janssen, J. W. G., Ottman, O. G., Seipeit, G., Eder, M., Becher, R., Lindermann, A., Herrmann, F., Schulz, G., Merteismann, R., Hoelzer, D. and Bartam, C. R. (1991) In vivo effects of granulocyte-macrophage colony-stimulating factor and interleukin-3 on clonal and non-clonal cell populations in patients with clonal hematopoietic disorders. Leukemia, 5, 487-492.
24. Greenberg, P. L., Mara, B., Bax, I., Brossel, R. and Schrier, S. (1976) The myeloproliferative disorders: Correlation between clinical evolution and alteration of granulopoiesis. Am. J. Med., 61, 878-891.
25. Faille, A., Dresch, C., Poirer, O., Balitrand, N. and Najean, Y. (1978) Prognostic value of in vitro bone marrow culture in refractory anaemia with excess of myeloblasts. Scand. J. Haematol., 20, 280-286.
26. Berthier, R., Douady, F., Metral, J., Newton, I., Schweitzer, A. and Holland, D. (1979) In vitro granulopoiesis in oligoblastic leukemia: Prognostic value, characterization and serial cloning of bone marrow colony and cluster forming cells in agar culture. Biomed., 30, 305-311.
27. Spitzer, G., Verma, D. S., Dicke, K. A., Smith, T. and McCredie, K. B. (1979) Subgroups of oligoleukemia as identified by in vitro agar culture. Leukemia Res., 3, 29-39.
28. Verma, D. S., Spitzer, G., Dicke, K. A. and McCredie, K. B. (1979) In vitro agar culture patterns in preleukemia and their clinical significance. Leukemia Res., 3, 41-49.
29. Karsdorf, A., Dresh, C., Metral, J. and Najean, Y. (1983) Prognostic value of the combined suicide level of granulocyte progenitors and the labelling index of precursors in preleukemic states and oligoblastic leukemias. Leukemia Res., 7, 279-286.
30. Raymakers R., De Witte, T., Joziasse, J., Van Der Lely, N., Boezeman, J. and Haanen, C. (1991) In vitro growth pattern and differentiation predict for progression of myelodysplastic syndromes to acute nonlymphocytic leukaemia. Br. J. Haematol., 78, 35-41.
31. Greenberg, P. L. (1986) In-vitro culture techniques defining biologic abnormalities in the myelodysplastic syndromes and myeloproliferative disorders. Clin. in Haematol., 15, 973-993.
32. Nagler, A., Binet, C., Mackichan, M. L., Negrin, R., Bangs, C., Donlon, T. and Greenberg, P. (1990) Impact of marrow cytogenetics and morphology on in vitro hematopoiesis in the myelodysplastic syndromes: Comparison between recombinant human granulocyte colony-stimulating factor (CSF) and granulocytemonocyte CSF. Blood, 76, 1299-1370.
33. Nagler, A., Ginzton, N., Negrin, R., Bang, D., Donlon, T. and Greenberg, P. (1990) Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemalopoiesis in the myelodysplastic syndromes. Leukemia, 4, 193-202.
34. Golde, D. W. and Cline, M. J. (1973) Human preleukemia: Identification of a maturation defect in vitro. N. Engl. J. Med., 288, 1083-1086.
35. Firkin, F. C., Birner, R., Russell, S. H. and Garson, M. (1990) Contrasting patterns of neoplastic cell behavior in long-term culture of bone marrow from patients with acute leukaemia and myelodysplastic disorders. Br. J. Haematol., 75, 476-484.
36. Schipperus, M., Sonneveld, P., Lindemans, J., Hagemeijer, A., Vink, N., Pegels, J. and Abels, J. (1990) The effects of interleukin-3, GM-CSF, and G-CSF on the growth kinetics of colony-forming cells in myelodysplastic syndromes. Leukemia, 4, 267-272.
37. + cells in serum-free medium: response to individual colony-stimulating factors. Br. J. Haematol., 83, 249-358.
38. Merchav, S., Wagemarker, G., Souza, L. M. and Tatarsky, I. (1991) Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant hematopoietic growth factors. Leukemia, 5, 340-346.
39. Mayani, H., Baines, P., Bowen, D. T. and Jacobs, A. (1989) In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte-macrophage colony-stimulating factor. Leukemia, 3, 29-32.
40. Thomas, X., Guyotat, D., Campos, L., Shi, Z. H., Vila, L., Ehrsam, A. and Fiere, D. (1991) In vitro effects of recombinant hemopoietic growth factors on progenitor cells from patients with myelodysplastic syndromes. Leukemia. Res., 15, 29-36.
41. + cells in serum-free medium: II. Response to combined colony-stimulating factors. Eur. J. Haematol., 54, 85-94.
42. McNiece, I. K., Langley, K. E. and Zsebo, K. M. (1991) Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and Epo to stimulate human progenitor cells in the myeloid and erythroid lineages. Exp. Hematol., 19, 226-231.
43. Broxmeyer, H. E., Cooper, S., Lu, L., Hangoc, G., Anderson, D., Cosman, D., Lyman, S. D. and Williams, D. E. (1991) Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells. Blood, 77, 2142-2149.
44. Backx, B., Broeders, L. and Löwenberg, B. (1992) Kit ligand improves in vitro erythropoiesis in myelodysplastic syndrome. Blood, 80, 1213-1217.
45. Maze, R., Horie, M., Hendrie, P., Vadhan-Raj, S., Tricot, G., Gordon, M., Nemunaitis, J., Ashman, L. K. and Broxmeyer, H. E. (1993) Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro. Exp. Hematol., 21, 545-551.
46. Piacibello, W., Sanavio, F., Bresso, P., Severino, A., Carlesso, N., Pregno, P., Stacchini, A., Morelli, S., Fubini, L., Gallo, E., Aglietta, M. and Ferrero, D. (1994) Stem cell factor improvement of proliferation and maintenance of hemopoietic progenitors in myelodysplastic syndromes. Leukemia, 8, 250-257.
47. Soligo, D., Servida, F., Cortelezzi, A., Pedretti, D., Morgutt, M., Pogliani, E. and Lambertenghi Deliliers, G. (1994) Effects of recombinant human stem cell factor (rh-SCF) on colony formation and long-term bone marrow cultures (LTBMC) in patients with myelodysplastic syndromes. Eur. J. Haematol., 52, 53-60.
48. Asano, H., Hotta, T., Ichihara, M., Murata, T., Kobayashi, M. and Saito, H. (1994) Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes. Leukemia, 8, 833-838.
49. Wu, H-K., Chiba, S., Hirai, H., Takaku, F. and Yazaki, Y. (1994) Effect of stem cell factor (c-kit ligand) on clonogenic leukemia precursor cells: Synergy with other hematopoietic growth factors. Am. J. Hematol., 47, 328-330.
50. Glinsmann-Gibson, B., Spier, C., Baier, M., Taetle, R., Broudy, V. C. and List, A. F. (1994) Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome. Leukemia, 8, 827-832.
51. Tohyama, K., Ueda, T., Yoshida, Y. and Nakamura, T. (1994) Altered responses of purified blast cells from the myelodysplastic syndromes to colony-stimulating factors in vitro: comparison with normal blast cells. Exp. Hematol., 22, 539-45.
52. Carlesso, N., Pregno, P., Bresso, P., Gallo, E., Pileri, A., Zsebo, K. M. and Ferrero, D. (1992) Human recombinanl stem cell factor stimulates in vitro proliferation of acute myeloid leukemia cells and expands the clonogenic cell pool. Leukemia, 6, 642-648.
53. Ikeda, H., Kanakura, Y., Tamaki, T., Kitayama, H., Ishikawa, J., Kanayama, Y., Yonezawa, T., Tarui, S. and Griffin, J. D. (1991) Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells. Blood, 78, 2962-2968.
54. Pietsch, T., Kyas, U., Steffens, U., Yakisan, E., Hadam, M. R., Ludwig, W-D., Zsebo, K. and Weite, K. (1992) Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors. Blood, 80, 1199-1206.
55. Pietsch, T., Kyas, U., Drexler, H. G. and Weite, K. (1993) Human stem cell factor is a growth factor for myeloid leukemia cells. Recent Results Cancer Res., 131, 329-338.
56. Asano, H., Ohashi, H., Ichihara, M., Kinoshita, T., Murate, T., Kobayashi, M., Saito, H. and Hotta, T. (1994) Evidence for non-clonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes. Blood, 84, 588-594.
57. Eaves, A. C. and Eaves, C. J. (1984) Erythropoiesis in culture. Clinics Hematol. 13, 371-391.
58. Nakahata, T. and Ogawa, M. (1982) Identification in culture of a class of hemopoietic colony-forming units with extensive capability to self-renewal and generate multipotential hemopoietic colonies. Proc. Natl Acad. Sci. U.S.A. 79, 3843-3847.
59. Gregory, C. J. and Henkelman, R. M. (1977) Relationship between early hemopoietic progenitor cells determined by correlation analysis of their numbers in individual spleen colonies. Baum, S. J. and Ledney, B. D. (eds) Experimental Hematology Today, Springer-Verlag, New York, p93-101.
60. Sawada, K., Krantz, S. B., Dai, C. H., Sato, N., Ieko, M., Sakurama, S., Yasukouchi, T. and Nakagawa, S. (1991) Transitional change of colony stimulating factor requirements for erythroid progenitors. J. Cell. Physiol., 149, 1-8.
61. Verfaillie, C., Blakolmer, K. and McGlave, P. (1990) Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma. J. Exp. Med., 172, 509-520.
62. Brandt, J., Srour, E. F., van Besien, K., Briddell, R. A. and Hoffman, R. (1990) Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow. J. Clin. Invest., 86, 932-941.
63. Lu, L., Walker, D., Broxmeyer, H. E., Hoffman, R., Hu, W. and Walker, E. (1987) Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies. J. Immunol., 139, 1823-1829.
64. Spangrude, G. J., Heimfeld, S. and Weissmanm, I. L. (1988) Purification and characterization of mouse hematopoietic stem cells. Science, 241, 58-62.
65. Ema, H., Suda, T., Miura, Y. and Nakauchi, H. (1990) Colony formation 2 of clone-sorted human hematopoietic progenitors. Blood, 75, 1941-1946.
66. Civin, C. I., Strauss, L. C., Fuckler, M. J., Trischmann, T. M., Wiley, J. M. and Loken, M. R. (1990) Positive stem cell selection: Basic science. In Bone Marrow Purging & Processing (Gross S, Gee A. Worthing-White D, eds.) Alan R Liss, New York, pp 387-402.
67. Sawada, K., Krantz, S. B., Dai, C. H., Koury, S. T., Horn, S. T., Click, A. D. and Civin, C. I. (1990) Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors. J. Cell. Physiol., 142, 219-230.
68. Sato, N., Sawada, K., Kannonji, M., Tarumi, T., Sakai, N., Ieko, M., Sakurama, S., Nakagawa, S., Yasukouchi, T and Krantz, S. B. (1991) Purification of human bone marrow progenitor cells and demonstration of the direct action of macrophage colony-stimulating factor on colony-forming unit-macrophage. Blood, 78, 967-974.
69. Civin, C. I., Strauss, L. C., Brovall, C., Fackler, M. J., Schwartz, J. F. and Shaper, J. H. (1984) Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-la cells. J. Immunol., 133, 157-165.
70. Buhring, H. J., Asenbauer, B., Katrilaka, K., Hummel, G. and Busch, F. W. (1989) Sequential expression of CD34 and CD33 antigens on myeloid colony-forming cells. Eur. J. Hematol., 42, 143-149.
71. Sawada, K., Sato, N., Notoya, A., Tarumi, T., Hirayama, S., Takano, H., Koizumi, K., Yasukouchi, T., Yamaguchi, M. and Koike, T. (1995) Proliferation and differentiation of myelodysplastic CD34+ cells: Phenotypic subpopulations of marrow CD34+ cells. Blood, 85, 194-202.
72. Strauss, L. C., Rowley, S. D., LaRussa, V. F., Sharkis, S. J., Stuart, R. K. and Civin, C. I. (1986) Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. Exp. Hematol., 14, 878-886.
73. Civin, C. I., Banquerigo, M. L., Straus, L. C. and Loken M. R. (1987) Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow. Exp. Hematol., 15, 10-17.
74. Loken, M. R., Shah, V, O., Dattilio, K. L. and Civin, C. I. (1987) Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood, 70, 1316-1324.
75. Ryan, D., Kossover, S., Mitchell, S., Frantz, C., Hennessy, L. and Cohen, H. (1986) Subpopulations of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens. Blood, 68, 417-425.
76. Leary, A. G., Ogawa, M., Strauss, L. C. and Civin, C. I. (1984) Single cell origin of multilineage colonies in culture: evidence that differentiation of multipotent progenitors and restriction of proliferative potential of monopotent progenitors are stochastic processes. J. Clin. Invest., 74, 2193-2197.
77. Schmitt, C., Eaves, C. J. and Lansdorp, P. M. (1991) Expression of CD34on human B cell precursors. Clin. Exp. Immunol., 85, 168-73.
78. Tindle, R. W., Nichols, R. A. B., Chan, L. C., Campana, D. and Birnie, G. (1984) A novel monoclonal antibody BI.3C5 recognizes myeloblasts and non B, non T lymphoblasts in acute leukemias and CGL blast crisis and reacts with immature cells in normal bone marrow. Leukemia Res., 9, 1-9.
79. Civin, C. I. (1990) Human monomyeloid cell membrane antigens. Exp. Hematol., 18, 461-467.
80. Terstappen, L. W. M. M., Huang, S., Safford, M., Lansdorp, P. M. and Loken, M. R. (1991) Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. Blood, 77, 1218-1227.
81. Knapp, W., Stockinger, H., Majdic, O., School, E., Tetteroo, P. A. T., Gadd, S., Koller, U. and Bettelheim, P. (1990) Myeloid antigens. In: Knap W et al. (eds) Leukocyte typing IV. Oxford University Press.
82. Civin, C. I. and Loken, M. R. (1987) Cell surface antigens on human marrow cells: dissection of hematopoietic development using monoclonal antibodies and multiparameter flow cytometry. Int. J. Cell Clon., 5, 267-288.
83. Griffin, J. D., Ritz, J., Nadler, L. M. and Schlossman, S. F. (1981) Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J. Clin. Invest., 68, 932-941.
84. Griffin, J. D., Ritz, J., Beveridge, R. P., Lipton, J. M., Daley, J. F. and Schlossman, S. F. (1983) Expression of My7 antigen on myeloid precursor cells. Int. J. Cell Clon., 1, 33-48.
85. Griffin, J. D., Mayer, R. J., Weinstein, H. J., Rosenthal, D. S., Coral, F. S., Beveridge, R. P. and Schlossman, S. F. (1983) Surface marker analysis of acute myeloblastic leukemia: identification of differentiation-associated phenotyes. Blood, 62, 557-563.
86. Carbonell, F., Heimpel, H., Kubanek, B. and Fliedner, T. (1985) Growth and cytogenetic characteristics of bone marrow colonies from patients with 5q-syndrome. Blood, 66, 463-465.
87. Bender, J. G., Unverzagt, K. L., Walker, D. E., Lee, W., Van Epps, D. E., Smith, D. H., Stewart, C. C. and To, L. B. (1991) Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood, 77, 2591-2596.
88. Egeland, T., Steen, R., Quarsten, H., Gaudernack, G., Yang, YuC. and Thorsby, E. (1991) Myeloid differentiation of purified CD34+ cells after stimulation with recombinant human granulocyte-monocyte colony-stimulating factor (CSF), granulocyteCSF, monocyte-CSF, and interleukin-3. Blood, 78, 3192-3199.
89. San Miguel, J. F., Gonzalez, M., Canizo, M. C., Anta, J. P., Hemandez, J., Ortega, F. and Lopez Borrasca, A. (1986) The nature of blast cells in myelodysplastic syndromes evolving to acute leukaemia. Blut, 52, 357-363.
90. Guyotat, D., Campos, L., Thomas, X., Vila, L., Shi, Z-H., Charrin, C. Gentilhomme, O. and Fiere, D. (1990) Myelodysplastic syndromes: A study of surface markers and in vitro growth patterns. Am. J. Hematol., 34, 26-31.
91. Hokland, P., Kerndrup, G., Griffin, J. D. and Ellegaard, J. (1986) Analysis of leukocyte differentiation antigens in blood and bone marrow from preleukemia (refractory anemia) patients using monoclonal antibodies. Blood, 67, 898-902.
92. Kerndrup, G., Bendix-Hansen, K., Pedersen, B., Ellegaard, J. and Hokland, P. (1988) Analysis of leukocyte differentiation antigens in blood and bone marrow in patients with refractory anaemia (RA) and RA with sideroblasts. Prognostic indications of sequential and follow-up data. Eur. J. Haematol., 41, 368-374.
93. Kristensen, J. S. and Hokland, P. (1990) Monoclonal antibody ratios in malignant myeloid diseases: diagnostic and prognostic use in myelodysplastic syndromes. Br. J. Haematol., 74, 270-276.
94. Thomas, X.,Guyotat, D., Campos, L., Shi, Z. H., Vila, L., Ehrsam, A. and Fiere, D. (1991) In vitro effects of recombinant hemopoietic growth factors on progenitor cells from patients with myelodysplastic syndromes. Leukemia Res., 15, 29-36.
95. Mittelman, M., Karcher, D. S., Kammerman, L. A. and Lessin, L. S. (1993) High la (HLA-DR) and low CD11b (Mol) expression may predict early conversion to leukemia in myelodysplastic syndromes. Am. J. Hematol., 43, 165-171.
96. Raskind, W. H.,Tirumali, N., Jacobson, R., Singer, J. and Fialkow, P. J (1984) Evidence fora multistep pathogenesis of a myelodysplastic syndrome. Blood, 63, 1318-1323.
97. Siitonen, T., Savolainen, E. R. and Koistinen, P. (1994) Expression of the c-kit proto-oncogene in myeloproliferative disorders and myelodysplastic syndromes. Leukemia, 8, 631-637.
98. Campos, L., Guyotat, D., Archimbaud, E., Devaux, Y., Treille, D , Larese, A., Maupas, J., Gentilhomme, O., Ehrsam, A. and Fiere, D. (1989) Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy. Br. J. Haematol., 72, 161-166.
99. Griffin, J. D., Davis, R., Nelson, D. A., Davey, F. R., Mayer, R. J., Schiffer, C., McIntyre, O. R. and Bloomfield, C. (1986) Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia. Blood, 68, 1232-1241.
100. Lepelley, P. Soenen, V., Preudhomme, C., Lai, J. L., Cosson, A and Fenaux, P. E. (1994) Expression of the multidrug resistance P-glycoprotein and its relationship to hernatological characteristics and response to treatment in myelodysplastic syndromes. Leukemia, 8, 998-1004.
101. Sonneveld, P., van Dongen, J. J., Hagemeijer, A., van Lom, K., Nooter, K., Schoester, M., Adriaansen, H. J., Tsuruo, T. and de Leeuw, K. (1993) High expression of the multidrug resistance P-glycoprotein in high-risk myelodysplasia is associated with immature phenotype. Leukemia, 7, 963-969.
102. Campos, L., Guyolat, D., Archimbaud, E., Calmard-Oriol, P., Tsuruo, T., Troney, J., Treille, D. and Fiere, D. (1992) Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood, 79, 473-476.
103. List, A. F., Spier, C. M., Cline, A., Doll, D. C., Garewal, H., Morgan, R. and Sandberg, A. A. (1991) Expression of the multidrug resistance gene product (P-glycoprotein) in myelodysplasia is associated with a stem cell phenotype. Br. J. Haematol., 78, 28-34.
104. Clark, R. E., Hoy, T. G. and Jacobs, A. (1985) Granulocyte and monocyte surface membrane markers in the myelodysplastic syndromes. J. Clin. Pathol., 38, 301-304.
105. Clark, R. E., Smith, S. A. and Jacobs, A. Myeloid surface antigen abnormalities in myelodysplasia: relation to prognosis and modification by 13-cis retinoic acid. J. Clin. Pathol., 40, 652-656.
106. San Miguel, J. F., Hernandez, J. M., Gonzalez-Sarmiento, R., Gonzalez, M., Sanchez, I., Orfao, A., Canizo, M. C. and Borrasca, A. L. (1991) Acute leukemia after a primary myelodysplastic syndrome: Immunophenotypic, genotypic, and clinical characteristics. Blood, 78, 768-774.
107. Look, A. T., Ashmun, R. A., Shapiro, L. H. and Peiper, S. C. (1989) Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J. Clin. Invest., 83, 1299-1307.
108. Look, A. T., Peiper, S. C., Rebentisch, M. B., Ashmun, R. A., Roussel, M. F., Rettenmier, C. W. and Sherr, C. J. (1985) Transfer and expression of the gene encoding a human myeloid membrane antigen (gp150). J. Clin. Invest., 75, 569-579.
109. O'Connell, P. J., Gerkis, V. and d'Apice, A. J. F. (1991) Variable O-glycosylation of CD 13 (aminopeptidase N). J. Biol. Chem., 266, 4593-4597.
110. Riemann, D., Gohring, B. and Langner, J. (1994) Expression of aminopeptidase N/CD13 in tumor-filtrating lymphocytes from human renal cell carcinoma. Immunol. Lett., 42, 19-23.
111. Noren, O., Sjostrom, H., Danielsen, E. M., Cowell, G. M. and Skovbjerg, H. (1986) The enzymes of the enterocyte plasma membrane, in Desnuelle, P. (ed): Molecular and Cellular Basis of Digestion. Amsterdam, The Netherlands, Elsevier/North-Holland, p335
112. Semenza, G. (1986) Anchoring and biosynthesis of stalked brush border membrane proteins: Glycosidases and peptidase of enterocytes and renal tubuli. Ann. Rev. Cell. Biol., 2, 255-313.
113. Matsas, R., Stephenson, S. L., Hryszko, J., Kenny, A. J. and Turner, A. J (1985) The metabolism of neuropeptides. Phase separation of synaptic membrane preparations with Triton X-114 reveals the presence of aminopeptidase N. Biochem. J., 231, 445-449.
114. Turner, A. J., Hooper, N. M. and Kenny, A. J. (1987) Metabolism of neuropeptides, in Kenny, A. J. and Turner, A. J. (eds): Mammalian Ectoenzymes. New York, NY, Elsevier Science, p211.
115. Turner, A. J., Matsas, R. and Kenny, A. J. (1985) Commentary: Are there neuropeptide-specific peptidases? Biochem. Pharmacol., 34, 1347-1356.
116. Saito, M., Aoyagi, T., Umezawa, H. and Nagai. Y. (1977) Bestatin. a new specific inhibitor of aminopeptidases, enhances activation of small lymphocytes by concanavalin A. Biochem. Biophys. Res. Commun., 76, 526-533.
117. Schorlemmer, H. U., Bosslet, K. and Sedlacck, H. H. (1983) Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes. Cancer Res., 43, 4148-4153.
118. Talmadge, J. E., Lentz, B. F., Pennington, R., Long, C., Phillips, H., Schneider, M. and Tribble, H. (1986) Immunomodulatory and therapeutic properties of bestatin in mice. Cancer Res., 46, 4505-4510.
119. Jarstrand, C. and Blomgren, H. (1982) Increased granulocyte phagocytosis after oral administration of bestatin, a new immunomodulator. J. Clin. Lab. Immunol., 7, 115-118.
120. Muller, W. E. G., Zahn, R. K., Arendes, J., Munsch, N. and Umezawa. H. (1979) Activation of DNA metabolism in T-cells by bestatin. Biochem. Pharmacol., 28, 3131-3137.
121. Kibbelaar, R E., van Kamp, H., Dreef, E. J., de Groot-Swings, G., Kluin-Nelemans, J. C., Beverstock, G. C., Fibbe, W. E. and Kluin, P. M. (1992) Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients withmyelodysplastic syndromes. Blood, 79, 1823-1828.
122. Amenomori, T., Tomonaga, M., Yoshido, Y., Kuriyama, K., Matsuo, T., Jinnai, I., Ichimaru, M., Omiya, A. and Tsuji, Y. (1986) Cytogenetic evidence for partially committed myeloid progenitor cell origin of chronic myelodysplastic leukemia and juvenile chronic myeloid leukemia: both granulocytes-macrophage precursors and erythroid precursors carry identical marker chromosome. Br. J. Haematol., 64, 539-546.
123. Gemtsen, W. R., Donohue, J., Bauman, J., Jhanwar, S. C., Kernan, N. A., Castro-Malaspina, H., O'Reilly, R. J. and Bourhis, J. H. (1992) Clonal analysis of myelodysplastic syndrome: Monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization. Blood, 80, 217-224.
124. Nylund, S. J., Verbeek, W., Larramendy, M. L., Ruutu, T., Heinonen, K., Hallman, H. and Knuutila, S. (1993) Cell lineage involvement in four patients with myelodysplastic syndrome and t(1;7) or trisomy 8 studied by simultaneous immunophenotyping and fluorescence in situ hybridization. Cancer Genet. Cytogenet., 70, 120-124.
125. Backx, B., Breeders, L., Touw, I. and Lowenberg, B. (1993) Blast colony-forming cells in myelodysplastic syndrome: Decreased potential to generate erythroid precursors. Leukemia, 7, 75-79.
126. Scheuten, H. C., Deiwel, R., Bot, F. J., Hagemeijer, A., Touw, I. P. and Lowenberg, B. (1989) Characterization of clonogenic cxells in refractory anemia with excess of blasts (RAEB-CFU): response to recombinant hematopoietic growth factors and maturation phenotypes. Leukemia Res., 13, 245-251.
127. Campos, L., Ffrench, M. and Guyotat, D. (1990) Myeloid differentiation antigens identify leukemic cell subpopulations with different cell cycle characteristics. Leukemia, 4, 60-62.